SCHEMBL5141502

SCHEMBL5141502

CNCCC(Oc1c(C)cccc1C)c1sccc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA2D1 P54289 9/20 0.45
SLC6A2 P23975 9/20 0.45
SLC6A4 P31645 9/20 0.45
SLC6A3 Q01959 6/20 0.45
CYP1A2 P05177 4/20 0.45
CYP3A4 P08684 4/20 0.45
CYP2D6 P10635 4/20 0.45
ADRA2B P18089 3/20 0.45
HTR2A P28223 3/20 0.45
HTR2C P28335 3/20 0.45
HRH1 P35367 3/20 0.45
OPRM1 P35372 3/20 0.45
DRD3 P35462 3/20 0.45
OPRK1 P41145 3/20 0.45
HTR2B P41595 3/20 0.45
KCNH2 Q12809 3/20 0.45
CHRM1 P11229 2/20 0.45
TSHR P16473 2/20 0.45
KLF10 Q13118 2/20 0.45
HRH3 Q9Y5N1 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL3810 0.93 SLC6A4 (0.42) CACNA2D1SLC6A2SLC6A4SLC6A3CYP1A2
Acetic Acid SCHEMBL27691872 0.75 SLC6A4 (0.60) CACNA2D1SLC6A2SLC6A4SLC6A3CYP1A2
SCHEMBL3811 0.73 ALOX5 (0.34)
SCHEMBL5137188 0.71 SLC6A4 (0.55) CACNA2D1SLC6A2SLC6A4SLC6A3CYP1A2
SCHEMBL15061181 0.69 ADRA1D (0.32) SLC6A4CYP1A2CYP3A4CYP2D6HTR2A
SCHEMBL14506463 0.64 SLC6A4 (0.55) CACNA2D1SLC6A2SLC6A4SLC6A3CYP1A2
SCHEMBL2487646 0.63 SLC6A4 (0.64) CACNA2D1SLC6A2SLC6A4SLC6A3CYP1A2
SCHEMBL15061262 0.63 SCN4A (0.32) SLC6A4CYP1A2CYP3A4CYP2D6HTR2A
SCHEMBL11239466 0.63 SLC6A4 (0.63) SLC6A2SLC6A4SLC6A3CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL4018637 0.62 SLC6A4 (0.62) CACNA2D1SLC6A2SLC6A4SLC6A3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008133884-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS COMBINATORX, INCORPORATED (US) 2008-11-06 WO disclosed